VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSX-V:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that it has become a member of the Cardiac Safety Technical Committee of the Health and Environmental Sciences […]
Tag: HESI
Recent
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation
Popular
- No commented posts yet